Fate Therapeutics, MIT Scientist Jaenisch Gets Stem Cell Patent
February 04, 2010, 05:23 PM EST
By Rob Waters
Feb. 4 (Bloomberg) — Rudolf Jaenisch, a Massachusetts Institute of Technology scientist, will be granted a U.S. patent for conceiving a way to turn cells from mammals’ bodies into stem cells.
The patent was announced by Fate Therapeutics Inc., a closely held San Diego company that has an exclusive license from MIT, and Jaenisch, one of the company’s founders.
via Fate Therapeutics, MIT Scientist Jaenisch Gets Stem Cell Patent – BusinessWeek.
More From Businessweek
* Kill Your Favorite Subsidy to Win the Deficit War: David Pauly
* Kim Doubles His North Korea Factory Visits, Emphasizing Economy
* Ex-Macquarie Property Chief Moss Sees Sagging Australian Prices
* Eastman Chemical, Sharp, IiNet: Intellectual Property (Update1)
* Fate Therapeutics, MIT Scientist Get Stem Cell Patent (Update1)